Our studies also uncovered that Smurf2 is a determinant of Topo IIα protein levels in cancer cells and tissues, and is a factor affecting tumor cell sensitivity to the Topo II-targeting drug, etoposide (40). The gene discussed is SMURF2; the disease is cancer.